Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
Jefferies Financial Group
JEF
|
+$501M |
| 2 |
Palo Alto Networks
PANW
|
+$350M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$306M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$290M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$262M |
Top Sells
| 1 |
Caterpillar
CAT
|
+$706M |
| 2 |
Apple
AAPL
|
+$683M |
| 3 |
Microsoft
MSFT
|
+$667M |
| 4 |
Flutter Entertainment
FLUT
|
+$586M |
| 5 |
NVIDIA
NVDA
|
+$499M |
Sector Composition
| 1 | Technology | 28.6% |
| 2 | Consumer Discretionary | 11.44% |
| 3 | Financials | 10.48% |
| 4 | Healthcare | 7.65% |
| 5 | Communication Services | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Goldman Sachs Hedge Industry VIP ETF
GVIP
$390M
| $68.4K | ﹤0.01% |
552
+1
| +0.2% | +$124 |
|
4002
Applied Therapeutics
APLT
$64M
| $68.4K | ﹤0.01% |
79,845
+10,178
| +15% | +$8.71K |
|
4003
Protara Therapeutics
TARA
$120M
| $68.4K | ﹤0.01% |
+12,945
| New | +$68.4K |
|
4004
Ultrapar
UGP
$4.05B
| $68.3K | ﹤0.01% |
25,969
-130,136
| -83% | -$342K |
|
4005
KORU Medical Systems
KRMD
$187M
| $68.3K | ﹤0.01% |
17,734
+17,715
| +93,237% | +$68.2K |
|
4006
Harvard Bioscience
HBIO
$20M
| $68.3K | ﹤0.01% |
32,358
+2,322
| +8% | +$4.9K |
|
4007
Invesco S&P 500 High Beta ETF
SPHB
$450M
| $68.3K | ﹤0.01% |
770
+516
| +203% | +$45.7K |
|
4008
Nautilus Biotechnolgy
NAUT
$89.3M
| $68.2K | ﹤0.01% |
40,572
+1,590
| +4% | +$2.67K |
|
|
VRNA
4009
Verona Pharma
VRNA
$9.2B
| $68.1K | ﹤0.01% |
1,466
+185
| +14% | +$8.59K |
|
4010
Black Diamond Therapeutics
BDTX
$192M
| $67.3K | ﹤0.01% |
31,469
+2,664
| +9% | +$5.7K |
|
4011
EVI Industries
EVI
$353M
| $67.2K | ﹤0.01% |
4,108
+376
| +10% | +$6.15K |
|
4012
Telefonica
TEF
$29.9B
| $66.8K | ﹤0.01% |
16,623
+539
| +3% | +$2.17K |
|
4013
Direxion Daily Technology Bull 3x Shares
TECL
$3.79B
| $66.4K | ﹤0.01% |
733
| – | – |
|
4014
Oaktree Specialty Lending
OCSL
$1.21B
| $65.8K | ﹤0.01% |
4,308
+980
| +29% | +$15K |
|
4015
Pyxis Oncology
PYXS
$116M
| $65.7K | ﹤0.01% |
42,088
+6,513
| +18% | +$10.2K |
|
4016
MoonLake Immunotherapeutics
MLTX
$3.44B
| $65.6K | ﹤0.01% |
+1,212
| New | +$65.6K |
|
4017
SB Financial Group
SBFG
$136M
| $65.4K | ﹤0.01% |
3,130
+751
| +32% | +$15.7K |
|
|
FINV
4018
FinVolution Group
FINV
$1.94B
| $65.4K | ﹤0.01% |
+9,637
| New | +$65.4K |
|
4019
iShares Core MSCI Europe ETF
IEUR
$6.94B
| $65.4K | ﹤0.01% |
1,212
| – | – |
|
4020
Gyre Therapeutics
GYRE
$742M
| $65.3K | ﹤0.01% |
5,399
+323
| +6% | +$3.91K |
|
4021
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.33B
| $65.2K | ﹤0.01% |
844
-2
| -0.2% | -$155 |
|
4022
TAT Technologies
TATT
$471M
| $64.6K | ﹤0.01% |
+2,517
| New | +$64.6K |
|
4023
ENI
E
$53B
| $64.5K | ﹤0.01% |
2,357
-538
| -19% | -$14.7K |
|
|
SDST
4024
Stardust Power Inc. Common Stock
SDST
$22.8M
| $64.3K | ﹤0.01% |
17,970
-920
| -5% | -$3.29K |
|
4025
Commercial Vehicle Group
CVGI
$70.3M
| $64.1K | ﹤0.01% |
25,862
+1,380
| +6% | +$3.42K |
|